Adaptive Biotechnologies Corp vs Iron Mountain Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Iron Mountain Inc trades at $122.41 (market cap $36.44B). The key difference: Iron Mountain Inc is far larger — about 9× Adaptive Biotechnologies Corp's market cap, and Iron Mountain Inc pays a 2.82% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | IRM | |
|---|---|---|
Market Cap | $4.04B | $36.44B |
Sector | Health | Real Estate |
52-Week High | $25.45 | $133.06 |
52-Week Low | $12.30 | $78.86 |
Enterprise Value | $4.10B | $55.85B |
Dividend Yield | — | 2.82% |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →